ストックスクリーナーアプリを入手
114.55
2.81%
-3.31
アフターアワーズ：
115.00
0.45
+0.39%
前日終値:
$117.86
開ける：
$117.49
24時間の取引高:
6.47M
Relative Volume:
0.99
時価総額：
$142.13B
収益：
$28.80B
当期純損益:
$6.31B
株価収益率:
22.82
EPS:
5.02
ネットキャッシュフロー:
$9.37B
1週間 パフォーマンス:
-0.43%
1か月 パフォーマンス:
-4.56%
6か月 パフォーマンス:
+0.49%
1年 パフォーマンス:
+37.75%
1日の値動き範囲:
$114.17
$117.63
1週間の範囲:
$113.82
$118.11
52週間の値動き範囲:
$81.57
$121.83
Gilead Sciences Inc Stock (GILD) Company Profile
GILD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GILD
Gilead Sciences Inc
|
114.55 | 143.00B | 28.80B | 6.31B | 9.37B | 5.02 |
|
LLY
Lilly Eli Co
|
755.39 | 676.48B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
178.06 | 423.36B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
218.34 | 373.87B | 58.33B | 3.73B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
124.12 | 244.98B | 53.40B | 13.68B | 16.89B | 6.9231 |
|
MRK
Merck Co Inc
|
82.81 | 209.89B | 63.43B | 16.42B | 14.72B | 6.49 |
Gilead Sciences Inc Stock (GILD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-19 | アップグレード | Daiwa Securities | Neutral → Outperform |
| 2025-08-08 | アップグレード | Truist | Hold → Buy |
| 2025-07-25 | アップグレード | Needham | Hold → Buy |
| 2025-04-22 | 再開されました | Cantor Fitzgerald | Overweight |
| 2025-03-04 | 繰り返されました | Oppenheimer | Outperform |
| 2025-02-18 | アップグレード | Deutsche Bank | Hold → Buy |
| 2025-02-13 | アップグレード | DZ Bank | Hold → Buy |
| 2025-01-10 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | 再開されました | BofA Securities | Buy |
| 2024-11-15 | 開始されました | Wolfe Research | Outperform |
| 2024-11-14 | 開始されました | Citigroup | Buy |
| 2024-11-08 | ダウングレード | Maxim Group | Buy → Hold |
| 2024-10-21 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-10-17 | 開始されました | Bernstein | Outperform |
| 2024-10-07 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-07-08 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2024-05-01 | 繰り返されました | Maxim Group | Buy |
| 2024-04-24 | アップグレード | HSBC Securities | Reduce → Hold |
| 2024-02-22 | ダウングレード | Truist | Buy → Hold |
| 2023-11-09 | 開始されました | Deutsche Bank | Hold |
| 2023-09-08 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-09-06 | 開始されました | HSBC Securities | Reduce |
| 2023-07-24 | 繰り返されました | Barclays | Equal Weight |
| 2023-05-16 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2023-04-28 | 再開されました | Piper Sandler | Overweight |
| 2023-01-03 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-12-13 | 再開されました | BofA Securities | Neutral |
| 2022-12-09 | ダウングレード | DZ Bank | Buy → Hold |
| 2022-10-31 | アップグレード | Barclays | Underweight → Equal Weight |
| 2022-10-28 | 繰り返されました | BMO Capital Markets | Market Perform |
| 2022-10-28 | 繰り返されました | Cowen | Outperform |
| 2022-10-28 | 繰り返されました | JP Morgan | Overweight |
| 2022-10-28 | 繰り返されました | Jefferies | Buy |
| 2022-10-28 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-10-28 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2022-10-28 | アップグレード | Truist | Hold → Buy |
| 2022-10-28 | 繰り返されました | Wells Fargo | Equal Weight |
| 2022-10-04 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-07-13 | 開始されました | Cantor Fitzgerald | Neutral |
| 2022-05-23 | 開始されました | SVB Leerink | Mkt Perform |
| 2022-02-28 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2022-02-02 | 繰り返されました | BMO Capital Markets | Outperform |
| 2022-02-02 | 繰り返されました | BofA Securities | Neutral |
| 2022-02-02 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2022-02-02 | 繰り返されました | Truist | Hold |
| 2022-02-02 | 繰り返されました | Wells Fargo | Equal Weight |
| 2022-01-28 | アップグレード | Argus | Hold → Buy |
| 2022-01-06 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-09 | 再開されました | Wells Fargo | Equal Weight |
| 2021-12-06 | 開始されました | Goldman | Neutral |
| 2021-11-19 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2021-11-19 | 再開されました | Piper Sandler | Neutral |
| 2021-10-20 | 再開されました | Cowen | Outperform |
| 2021-07-30 | 繰り返されました | BMO Capital Markets | Market Perform |
| 2021-07-30 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2021-04-01 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2021-03-30 | アップグレード | Redburn | Neutral → Buy |
| 2021-01-19 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-01-04 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-11-03 | 再開されました | Morgan Stanley | Equal-Weight |
| 2020-10-28 | 開始されました | UBS | Neutral |
| 2020-09-30 | 再開されました | Jefferies | Buy |
| 2020-09-15 | アップグレード | Maxim Group | Hold → Buy |
| 2020-07-31 | 繰り返されました | Credit Suisse | Neutral |
| 2020-07-31 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2020-07-31 | 繰り返されました | Piper Sandler | Overweight |
| 2020-07-31 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2020-07-31 | 繰り返されました | SunTrust | Hold |
| 2020-07-31 | 繰り返されました | Wells Fargo | Equal Weight |
| 2020-07-20 | アップグレード | Credit Suisse | Underperform → Neutral |
| 2020-06-03 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2020-05-26 | アップグレード | SunTrust | Sell → Hold |
| 2020-05-01 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-05-01 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-05-01 | ダウングレード | SunTrust | Hold → Sell |
| 2020-04-27 | ダウングレード | UBS | Buy → Neutral |
| 2020-04-20 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2020-04-20 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | ダウングレード | CFRA | Hold → Sell |
すべてを表示
Gilead Sciences Inc (GILD) 最新ニュース
Kestra Investment Management LLC Sells 2,391 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
CTC Alternative Strategies Ltd. Invests $784,000 in Gilead Sciences, Inc. $GILD - MarketBeat
Ascent Group LLC Raises Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Strs Ohio Buys Shares of 512,180 Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Sold by Jacobi Capital Management LLC - MarketBeat
Acadian Asset Management LLC Buys 189,569 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
WBI Investments LLC Sells 7,266 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
SCS Capital Management LLC Invests $853,000 in Gilead Sciences, Inc. $GILD - MarketBeat
Here's How You Can Earn $100 In Passive Income By Investing In Gilead Sciences Stock - Yahoo Finance
Gilead beats whistleblower lawsuit over hepatitis C drugs - Reuters
UniSuper Management Pty Ltd Acquires 137,308 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead prevails in whistleblower lawsuit over alleged hepatitis C prescription kickbacks - Fierce Pharma
Gilead Sciences, Inc. $GILD Shares Sold by Intech Investment Management LLC - MarketBeat
Gilead Defeats Whistleblower’s Hepatitis C Kickback Suit (1) - Bloomberg Law News
Ilmarinen Mutual Pension Insurance Co Has $21.85 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
Glenview Trust co Increases Position in Gilead Sciences, Inc. $GILD - MarketBeat
Rothschild & Co Redburn Adjusts Gilead Sciences Price Target to $143 From $136, Maintains Buy Rating - MarketScreener
Gilead Sciences, Inc. : The underlying trend is in force again - MarketScreener
Gilead Sciences, Inc. $GILD Shares Acquired by Fred Alger Management LLC - MarketBeat
Gilead Sciences stock price target raised to $143 from $136 at Rothschild Redburn - Investing.com
State of Wyoming Decreases Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences (GILD) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
Gilead Sciences Commits To Veeva Systems (VEEV) For Vault CRM Suite - simplywall.st
Ex-Dividend Reminder: Gilead Sciences, Thermo Fisher Scientific and Merck - Nasdaq
Sanofi wins big at the 2025 Fierce Pharma Marketing Awards - Fierce Pharma
Zurich Insurance Group Ltd FI Cuts Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Cinctive Capital Management LP Cuts Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Acquired by Meiji Yasuda Life Insurance Co - MarketBeat
Continental Advisors LLC Decreases Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Voleon Capital Management LP Lowers Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Sold by Gotham Asset Management LLC - MarketBeat
SLB, Apple, Nvidia, Merck, Gilead Sciences: What Sparked Heavy After-Hours Trading In These 5 Stocks? - Stocktwits
Gilead Sciences, Inc. $GILD Stake Decreased by Parkman Healthcare Partners LLC - MarketBeat
Gilead, Moderna to see upside if RFK Jr. leaves HHS: RBC - MSN
Gilead at Baird Global Healthcare Conference: Expanding Cell Therapy Horizons - Investing.com
Gilead Sciences Commits to Veeva Vault CRM - Contract Pharma
Curi RMB Capital LLC Has $8.92 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences Commits to Veeva Vault Crm - MarketScreener
Should Income Investors Look At Gilead Sciences, Inc. (NASDAQ:GILD) Before Its Ex-Dividend? - 富途牛牛
Veeva Systems says Gilead Sciences commits to Veeva Vault CRM - MarketScreener
Gilead Sciences commits to Veeva Vault CRM - Investing.com
Veeva Systems Expands Partnership With Gilead Sciences - MarketScreener
Veeva Systems partners with Gilead for Vault CRM (VEEV:NYSE) - Seeking Alpha
Veeva Systems Gilead Sciences California - AD HOC NEWS
Gilead Sciences commits to Veeva Vault CRM platform - StreetInsider
Life Sciences Giant Gilead Sciences Adopts Veeva's Next-Gen AI-Powered CRM Platform for Commercial Operations - Stock Titan
Great Lakes Advisors LLC Grows Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead fashions new primary biliary cholangitis campaign alongside 'Project Runway' designer - Fierce Pharma
US Cystic Fibrosis Therapeutics Market Forecast and Company Analysis Report 2025-2033 Featuring Vertex, Abbvie, Novartis, Gilead Sciences, Viatris, Pfizer, AstraZeneca, and F. Hoffmann-La Roche - Yahoo Finance
Nissay Asset Management Corp Japan ADV Boosts Position in Gilead Sciences, Inc. $GILD - MarketBeat
Xilio Stock Jumps 8% On Cancer Drug Data; Gilead Boost Extends Cash Runway Into 2027 — Retail Says Stock Undervalued - MSN
Gilead Sciences Inc (GILD) 財務データ
収益
当期純利益
現金流量
EPS
3.98%
1.05%
大文字化:
|
ボリューム (24 時間):